SMN2 and proximal spinal muscular atrophy: The factors for determining the choice of treatment, ranked from most to least important, were treatment efficacy, route/frequency of administration, SMN2 copy number, the presence of symptoms of SMA, the side-effect profile, the mechanism of action, insurance authorization, and cost.